The largest database of trusted experimental protocols

6 protocols using anti mouse cd4 antibody

1

Comprehensive Immune Profiling Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
ViaStain AO/PI Staining Solution (catalog#CS2-0106) was purchased from Nexcelom. Propidium Iodide Solution (catalog#421301) was purchased from BioLegend. CellTrace CFSE Cell Proliferation Kit (catalog#C34554) was purchased from ThermoFisher. LIVE/DEAD Fixable Blue Dead Cell Stain Kit (catalog#L23105) was purchased from ThermoFisher. Anti-mouse CD73 antibody (clone: TY/23, catalog#BE0209), Anti-mouse B7H3 antibody (clone: MJ18, catalog#BE0124), anti-mouse PD-1 antibody (clone: RMP1-14, catalog#BE0146), anti-mouse CTLA-4 antibody (clone: UC10-4F10-11, catalog#BE0032), anti-mouse TIM-3 antibody (clone: RMT3-23, catalog#BE0115), anti-mouse TIGIT antibody (clone: 1G9, catalog#BE0274), anti-mouse LAG-3 antibody (clone: C9B7W, catalog#BE0174), anti-mouse GITR antibody (clone: DTA-1, catalog#BE0063), anti-mouse OX-40 antibody (clone: OX-86, catalog#BE0031), anti-mouse 401BB antibody (clone: LOB12.3, catalog#BE0169), anti-mouse NK1.1 antibody (clone: PK136, catalog#BE0036), anti-mouse CD4 antibody (clone: GK1.5, catalog#BE0003-1), and anti-mouse CD8 antibody (clone: 2.43, catalog#BE0061) were purchased from BioXcell. Anti-human PD-1 (Nivolumab, catalog#A2002) was purchased from Selleckchem. Anti-human CD73 (clone: AD2, catalog#344002) was purchased from BioLegend.
+ Open protocol
+ Expand
2

Modulation of Immune Responses in Leishmaniasis

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4+ T cells were selectively depleted with 0.5 mg anti-mouse CD4 antibody (clone: GK1.5; BioXCell) administered via intraperitoneal injection every 3 days over a two week period (Bunn et al., 2014 (link)). Similarly, neutralization of type I IFN and IFNγ signaling was achieved via administration of 0.1 mg purified anti-mouse IFNAR-1 antibody (clone: MAR1-5A3; Haque et al., 2014 (link)) or 0.5 mg anti-mouse IFNγ (clone: XMG1.2; Haque et al., 2011 (link)), respectively, every 3 days over a two week period. Control mice received an equivalent amount of rat IgG (Sigma-Aldrich). For anti-parasitic drug treatment experiments, mice were infected for 14 days with L. donovani before being treated with either a single, low dose of AmBisome (Amblo; 1 mg/kg) or a single, high dose of AmBisome (Ambhi; 10 mg/kg) i.v.. Some mice received 60 mg/kg ruxolitinib (Rux; ChemieTek) orally, twice daily for 5 days, based on dosing used in mice by others (Bhagwat et al., 2014 (link); Xing et al., 2014 (link)), or the same volume (200 μl) of vehicle (DMAc; Sigma-Aldrich).
+ Open protocol
+ Expand
3

Modulation of Immune Responses in Leishmaniasis

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4+ T cells were selectively depleted with 0.5 mg anti-mouse CD4 antibody (clone: GK1.5; BioXCell) administered via intraperitoneal injection every 3 days over a two week period (Bunn et al., 2014 (link)). Similarly, neutralization of type I IFN and IFNγ signaling was achieved via administration of 0.1 mg purified anti-mouse IFNAR-1 antibody (clone: MAR1-5A3; Haque et al., 2014 (link)) or 0.5 mg anti-mouse IFNγ (clone: XMG1.2; Haque et al., 2011 (link)), respectively, every 3 days over a two week period. Control mice received an equivalent amount of rat IgG (Sigma-Aldrich). For anti-parasitic drug treatment experiments, mice were infected for 14 days with L. donovani before being treated with either a single, low dose of AmBisome (Amblo; 1 mg/kg) or a single, high dose of AmBisome (Ambhi; 10 mg/kg) i.v.. Some mice received 60 mg/kg ruxolitinib (Rux; ChemieTek) orally, twice daily for 5 days, based on dosing used in mice by others (Bhagwat et al., 2014 (link); Xing et al., 2014 (link)), or the same volume (200 μl) of vehicle (DMAc; Sigma-Aldrich).
+ Open protocol
+ Expand
4

Depletion of Immune Cells in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
For CD4+ T cells depletion, mice were inoculated intraperitoneally with 500 μg of anti-mouse CD4 antibody (Clone: GK1.5; Bio X Cell) at −1 and 4 dpi. For GM-CSF depletion, mice were inoculated intraperitoneally with 250 μg of anti-mouse GM-CSF antibodies (Clone: MP1-22E9; Bio X Cell) at 4 dpi. For IFNγ depletion, mice were inoculated intraperitoneally with 500 μg of anti-mouse IFNγ antibody (Clone: XMG1.2; Bio X Cell) at 0, 2, and 4 dpi. All drugs given were prepared in 100 μL volume diluted in sterile PBS. Control animals were given 100 μL of PBS, to ensure that in these animals, the infection will resemble as closely as possible to non-treated animals. Appendix Fig. S1 shows that disease severity and viral load clearance were comparable between animals receiving PBS and isotype control antibodies. Macrophages were depleted with clodronate liposomes (LIPOSOMA) given intravenously at 5 dpi. Clodronate liposomes were given at a final concentration of 1 mg/mL, in a volume of 200 μL. Control animals were given empty liposomes (LIPOSOMA).
+ Open protocol
+ Expand
5

Comprehensive Immune Profiling Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
ViaStain AO/PI Staining Solution (catalog#CS2-0106) was purchased from Nexcelom. Propidium Iodide Solution (catalog#421301) was purchased from BioLegend. CellTrace CFSE Cell Proliferation Kit (catalog#C34554) was purchased from ThermoFisher. LIVE/DEAD Fixable Blue Dead Cell Stain Kit (catalog#L23105) was purchased from ThermoFisher. Anti-mouse CD73 antibody (clone: TY/23, catalog#BE0209), Anti-mouse B7H3 antibody (clone: MJ18, catalog#BE0124), anti-mouse PD-1 antibody (clone: RMP1-14, catalog#BE0146), anti-mouse CTLA-4 antibody (clone: UC10-4F10-11, catalog#BE0032), anti-mouse TIM-3 antibody (clone: RMT3-23, catalog#BE0115), anti-mouse TIGIT antibody (clone: 1G9, catalog#BE0274), anti-mouse LAG-3 antibody (clone: C9B7W, catalog#BE0174), anti-mouse GITR antibody (clone: DTA-1, catalog#BE0063), anti-mouse OX-40 antibody (clone: OX-86, catalog#BE0031), anti-mouse 401BB antibody (clone: LOB12.3, catalog#BE0169), anti-mouse NK1.1 antibody (clone: PK136, catalog#BE0036), anti-mouse CD4 antibody (clone: GK1.5, catalog#BE0003-1), and anti-mouse CD8 antibody (clone: 2.43, catalog#BE0061) were purchased from BioXcell. Anti-human PD-1 (Nivolumab, catalog#A2002) was purchased from Selleckchem. Anti-human CD73 (clone: AD2, catalog#344002) was purchased from BioLegend.
+ Open protocol
+ Expand
6

Syngeneic Tumor Models in Genetically Engineered Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Unless otherwise specified, 100,000 breast cancer cells were injected s.c. adjacent to the inguinal mammary fat pad of female WT, Rag1KO, Batf3KO, Ifnar1KO, StingKO, Ticam1KO Myd88KO, Ccr5KO Cxcr3KO, Ifnar1KO, and Cxcr3 KO mice on the C57BL/6 background. 500,000 D4M.3A.3 melanoma and melanoma-MT cells were injected subcutaneously into the flanks of DMBA3-4-immunized and naive mice on the C57BL/6 background. In the LLC tumor model, 1,000,000 LLC cells were injected s.c. into flanks of naive mice on the C57BL/6 background. For macrophage and T cell depletion, clodronate liposome (catalog no. PBS-02, Liposoma BV), anti-mouse CD4 antibody (catalog no. BE0003, Bio X Cell), and anti-mouse CD8β antibody (catalog no. BE0223, Bio X Cell) were i.p. injected once a week, respectively. For natural killer cell depletion, Ncr1iCre, ROSADTR mice were treated with diphtheria toxin (catalog no. D0564, Sigma-Aldrich) as well as anti-NK1.1 antibody (catalog no. BE0036, Bio X Cell). For DC depletion, CD11c-DTR mice were treated with diphtheria toxin. Tumor growth was monitored daily and measured on regular intervals. When a tumor reached 2 cm in diameter or became ulcerated, it was deemed terminal. In the lung metastasis mouse model, 500,000 DMBA3-4 versus DMSO3-1 cells were i.v. injected into tail vein of WT mice on the C57BL/6 background.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!